| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f1eefddf3b800d65a4b23f8c9215848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e58d947cc47bd5e0b313f8337dafa118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0423403211d76b246d86663dc5343b66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c50ae47e4477a8ea4d83c79783382d9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_874ab6af05c834227695afe3312175b4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y401-01022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14 |
| filingDate |
2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12a3a95148481976e74294258ed95c79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed246c3643a0cb291f34e7bedd8cbad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5f907a133fd08df02b29ce46d2c78e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee545b63556d0181fa515cb5b08a108a |
| publicationDate |
2007-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007053558-A2 |
| titleOfInvention |
Vancomycin formulations having reduced amount of histamine |
| abstract |
A time-released formulation of vancomycin. The invention also includes a vancomycin composition having a reduced level of histamine and a process for reducing the level of histamine in a vancomycin composition. The invention also includes a pharmaceutical composition containing vancomycin that reduces the incidence of Red Man Syndrome, phlebitis, and hypotension. The invention further includes a histamine-free growth media that supports growth of Amycolatopsis orientalis and the fermentation of vancomycin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108642110-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108642110-B |
| priorityDate |
2005-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |